Breast Cancer Trial, Recruiting (NCT07524829)

Breast Cancer Trial, Recruiting NCT07524829 Sponsor: Azienda Sanitaria Locale di Asti Condition: Breast Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT07524829 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Breast Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Women aged 18 years or older
People who have been diagnosed with breast cancer confirmed through a tissue or biopsy test
People who are currently receiving treatment with a type of cancer medication called a CDK 4/6 inhibitor (examples include palbociclib, ribociclib, or abemaciclib)
People who are able to understand the study information and agree to take part
People who have access to a phone or digital device (such as a tablet or computer) for remote check-ins with a nurse

Who may not be able to join:

People who would be unable to follow the study procedures as required
People with cognitive difficulties or mental health conditions that would make participation difficult
People who are already taking part in another clinical trial that could affect the results of this study
People with serious other health conditions that significantly limit life expectancy or the ability to complete follow-up appointments

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 8 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: MANUELA CANICATTI', RN, MSc, PhD(c), ASL AT

Phone: +39 3297278131

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07524829

Sponsor: Azienda Sanitaria Locale di Asti

Phase: Not Applicable

Status: Recruiting

Condition: Breast Cancer

Trial contact: +39 3297278131

More information: https://clinicaltrials.gov/study/NCT07524829

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Women aged 18 years or older
People who have been diagnosed with breast cancer confirmed through a tissue or biopsy test
People who are currently receiving treatment with a type of cancer medication called a CDK 4/6 inhibitor (examples include palbociclib, ribociclib, or abemaciclib)
People who are able to understand the study information and agree to take part
People who have access to a phone or digital device (such as a tablet or computer) for remote check-ins with a nurse

Who may not be able to join:

People who would be unable to follow the study procedures as required
People with cognitive difficulties or mental health conditions that would make participation difficult
People who are already taking part in another clinical trial that could affect the results of this study
People with serious other health conditions that significantly limit life expectancy or the ability to complete follow-up appointments

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 8 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Azienda Sanitaria Locale di Asti

Registry

ClinicalTrials.gov

Start date

9 April 2024

Est. completion

1 April 2028

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Incidence of treatment-related adverse events assessed by CTCAE (v5.0)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov